Chiasma Inc. [NASDAQ: CHMA] plunged by -$0.49 during the normal trading session on Wednesday and reaching a high of $3.52 during the day while it closed the day at $3.02. The company report on March 23, 2021 that Chiasma Presents Long-Term Safety and Efficacy Data from the Open-Label Extension Study of its CHIASMA OPTIMAL Phase 3 Trial Evaluating MYCAPSSA® in Patients with Acromegaly at ENDO 2021.
–93% of all patients who enrolled as a responder to MYCAPSSA® maintained their biochemical response at the end of the 48-week open-label extension (OLE) period–.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
–Safety profile during the OLE was generally consistent with the safety observed in the CHIASMA OPTIMAL trial.
Chiasma Inc. stock has also loss -10.65% of its value over the past 7 days. However, CHMA stock has declined by -34.77% in the 3 months of the year. Over the past six months meanwhile, it has lost -38.74% and lost -30.57% year-on date.
The market cap for CHMA stock reached $171.11 million, with 62.88 million shares outstanding and 57.42 million shares in the current float. Compared to the average trading volume of 1.64M shares, CHMA reached a trading volume of 5656349 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Chiasma Inc. [CHMA]:
Jefferies have made an estimate for Chiasma Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 13, 2020. While these analysts kept the previous recommendation, Piper Jaffray raised their target price to Overweight. The new note on the price target was released on July 31, 2019, representing the official price target for Chiasma Inc. stock. Previously, the target price had yet another raise to $11, while H.C. Wainwright analysts kept a Buy rating on CHMA stock. On January 17, 2017, analysts decreased their price target for CHMA shares from 5.50 to 2.50.
The Average True Range (ATR) for Chiasma Inc. is set at 0.25, with the Price to Sales ratio for CHMA stock in the period of the last 12 months amounting to 155.56. The Price to Book ratio for the last quarter was 2.07, with the Price to Cash per share for the same quarter was set at 2.39.
CHMA stock trade performance evaluation
Chiasma Inc. [CHMA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -10.65. With this latest performance, CHMA shares dropped by -22.76% in over the last four-week period, additionally sinking by -38.74% over the last 6 months – not to mention a drop of -19.03% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CHMA stock in for the last two-week period is set at 32.67, with the RSI for the last a single of trading hit 29.89, and the three-weeks RSI is set at 34.74 for Chiasma Inc. [CHMA]. The present Moving Average for the last 50 days of trading for this stock 3.87, while it was recorded at 3.34 for the last single week of trading, and 4.47 for the last 200 days.
Chiasma Inc. [CHMA]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Chiasma Inc. [CHMA] shares currently have an operating margin of -6387.79 and a Gross Margin at +94.48. Chiasma Inc.’s Net Margin is presently recorded at -6761.21.
Return on Equity for this stock declined to -84.23, with Return on Assets sitting at -54.35.
Receivables Turnover for the company is 4.11 with a Total Asset Turnover recorded at a value of 0.01.Chiasma Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.50 and a Current Ratio set at 9.20.
Earnings per share (EPS) analysis for Chiasma Inc. [CHMA] stock
With the latest financial reports released by the company, Chiasma Inc. posted -0.36/share EPS, while the average EPS was predicted by analysts to be reported at -0.32/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -12.50%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CHMA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Chiasma Inc. go to 46.30%.
Chiasma Inc. [CHMA]: Insider Ownership positions
There are presently around $119 million, or 71.90% of CHMA stock, in the hands of institutional investors. The top three institutional holders of CHMA stocks are: MPM ASSET MANAGEMENT LLC with ownership of 5,736,296, which is approximately 0% of the company’s market cap and around 0.30% of the total institutional ownership; BLACKROCK INC., holding 4,240,044 shares of the stock with an approximate value of $12.8 million in CHMA stocks shares; and ADAGE CAPITAL PARTNERS GP, L.L.C., currently with $12.08 million in CHMA stock with ownership of nearly -18.367% of the company’s market capitalization.
Positions in Chiasma Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 45 institutional holders increased their position in Chiasma Inc. [NASDAQ:CHMA] by around 4,599,106 shares. Additionally, 35 investors decreased positions by around 6,507,415 shares, while 19 investors held positions by with 28,223,656 shares. The mentioned changes placed institutional holdings at 39,330,177 shares, according to the latest SEC report filing. CHMA stock had 14 new institutional investments in for a total of 959,235 shares, while 13 institutional investors sold positions of 2,876,166 shares during the same period.